Display options
Share it on

J Int Soc Sports Nutr. 2012 Sep 20;9(1):45. doi: 10.1186/1550-2783-9-45.

Probiotic supplementation affects markers of intestinal barrier, oxidation, and inflammation in trained men; a randomized, double-blinded, placebo-controlled trial.

Journal of the International Society of Sports Nutrition

Manfred Lamprecht, Simon Bogner, Gert Schippinger, Kurt Steinbauer, Florian Fankhauser, Seth Hallstroem, Burkhard Schuetz, Joachim F Greilberger

Affiliations

  1. Institute of Physiological Chemistry, Centre for Physiological Medicine, Medical University of Graz, Graz, Austria. [email protected].

PMID: 22992437 PMCID: PMC3465223 DOI: 10.1186/1550-2783-9-45

Abstract

BACKGROUND: Probiotics are an upcoming group of nutraceuticals claiming positive effects on athlete's gut health, redox biology and immunity but there is lack of evidence to support these statements.

METHODS: We conducted a randomized, double-blinded, placebo controlled trial to observe effects of probiotic supplementation on markers of intestinal barrier, oxidation and inflammation, at rest and after intense exercise. 23 trained men received multi-species probiotics (1010 CFU/day, Ecologic®Performance or OMNi-BiOTiC®POWER, n = 11) or placebo (n = 12) for 14 weeks and performed an intense cycle ergometry over 90 minutes at baseline and after 14 weeks. Zonulin and α1-antitrypsin were measured from feces to estimate gut leakage at baseline and at the end of treatment. Venous blood was collected at baseline and after 14 weeks, before and immediately post exercise, to determine carbonyl proteins (CP), malondialdehyde (MDA), total oxidation status of lipids (TOS), tumor necrosis factor-alpha (TNF-α), and interleukin-6 (IL-6). Statistical analysis used multifactorial analysis of variance (ANOVA). Level of significance was set at p < 0.05, a trend at p < 0.1.

RESULTS: Zonulin decreased with supplementation from values slightly above normal into normal ranges (<30 ng/ml) and was significantly lower after 14 weeks with probiotics compared to placebo (p = 0.019). We observed no influence on α1-antitrypsin (p > 0.1). CP increased significantly from pre to post exercise in both groups at baseline and in the placebo group after 14 weeks of treatment (p = 0.006). After 14 weeks, CP concentrations were tendentially lower with probiotics (p = 0.061). TOS was slightly increased above normal in both groups, at baseline and after 14 weeks of treatment. There was no effect of supplementation or exercise on TOS. At baseline, both groups showed considerably higher TNF-α concentrations than normal. After 14 weeks TNF-α was tendentially lower in the supplemented group (p = 0.054). IL-6 increased significantly from pre to post exercise in both groups (p = 0.001), but supplementation had no effect. MDA was not influenced, neither by supplementation nor by exercise.

CONCLUSIONS: The probiotic treatment decreased Zonulin in feces, a marker indicating enhanced gut permeability. Moreover, probiotic supplementation beneficially affected TNF-α and exercise induced protein oxidation. These results demonstrate promising benefits for probiotic use in trained men.

CLINICAL TRIAL REGISTRY: http://www.clinicaltrials.gov, identifier: NCT01474629.

References

  1. Exerc Immunol Rev. 2009;15:107-26 - PubMed
  2. FASEB J. 2002 Sep;16(11):1335-47 - PubMed
  3. J Nutr. 2007 Dec;137(12):2737-41 - PubMed
  4. FEMS Microbiol Lett. 2010 Aug 1;309(2):184-92 - PubMed
  5. Am J Gastroenterol. 2008 Jan;103(1):178-89 - PubMed
  6. Int J Sport Nutr Exerc Metab. 2011 Feb;21(1):55-64 - PubMed
  7. Am J Hum Biol. 2000 Mar;12(2):221-230 - PubMed
  8. J Cell Sci. 2000 Dec;113 Pt 24:4435-40 - PubMed
  9. PLoS One. 2007 Dec 12;2(12):e1308 - PubMed
  10. J Nutr. 2011 May;141(5):769-76 - PubMed
  11. Free Radic Biol Med. 1999 Nov;27(9-10):1080-6 - PubMed
  12. Int J Sport Nutr Exerc Metab. 2009 Aug;19(4):385-99 - PubMed
  13. Gut. 2001 Aug;49(2):159-62 - PubMed
  14. J Chromatogr B Biomed Sci Appl. 2000 Jun 9;742(2):315-25 - PubMed
  15. Gut. 1987 May;28(5):583-7 - PubMed
  16. Br J Nutr. 1998 Aug;80 Suppl 1:S147-71 - PubMed
  17. Am J Physiol Gastrointest Liver Physiol. 2010 Jun;298(6):G851-9 - PubMed
  18. Br J Sports Med. 2010 Mar;44(4):222-6 - PubMed
  19. J Anim Sci. 2009 Apr;87(14 Suppl):E101-8 - PubMed
  20. Exp Gerontol. 2001 Sep;36(9):1495-502 - PubMed
  21. J Appl Physiol (1985). 1997 Feb;82(2):571-6 - PubMed
  22. Inflamm Bowel Dis. 2010 Mar;16(3):410-27 - PubMed
  23. J Allergy Clin Immunol. 2009 Jul;124(1):3-20; quiz 21-2 - PubMed
  24. Int J Sport Nutr Exerc Metab. 2007 Aug;17(4):352-63 - PubMed
  25. J Appl Physiol. 1974 Aug;37(2):247-8 - PubMed
  26. Clin Rev Allergy Immunol. 2012 Feb;42(1):71-8 - PubMed
  27. Gastroenterology. 2002 Nov;123(5):1607-15 - PubMed
  28. Gastroenterology. 1990 Nov;99(5):1380-7 - PubMed
  29. Nutr J. 2011 Apr 11;10:30 - PubMed
  30. J Pediatr Gastroenterol Nutr. 2003 Nov;37(5):577-80 - PubMed
  31. Ann Intern Med. 1987 Jan;106(1):114-29 - PubMed
  32. Physiol Rev. 2011 Jan;91(1):151-75 - PubMed
  33. Scand J Gastroenterol. 1992 Apr;27(4):270-4 - PubMed
  34. Scand J Gastroenterol. 1997 Sep;32(9):920-4 - PubMed
  35. Proc Natl Acad Sci U S A. 2011 Mar 15;108 Suppl 1:4607-14 - PubMed
  36. Gastroenterology. 2006 Mar;130(3):731-46 - PubMed
  37. Dig Dis Sci. 1990 Feb;35(2):276-9 - PubMed
  38. Diabetes. 2006 May;55(5):1443-9 - PubMed
  39. J Appl Physiol (1985). 2005 Apr;98(4):1154-62 - PubMed
  40. Clin Sci (Lond). 2000 Jan;98(1):47-55 - PubMed
  41. Gastroenterology. 2007 Apr;132(4):1359-74 - PubMed
  42. Curr Microbiol. 2011 Jun;62(6):1689-96 - PubMed
  43. J Int Soc Sports Nutr. 2011 Sep 28;8:12 - PubMed
  44. Int Rev Immunol. 2009;28(6):414-45 - PubMed
  45. Med Sci Sports Exerc. 2009 Jan;41(1):155-63 - PubMed
  46. Free Radic Biol Med. 1991;11(1):81-128 - PubMed
  47. Ann Indian Acad Neurol. 2008 Jan;11(1):44-6 - PubMed
  48. BMC Microbiol. 2009 Mar 31;9:63 - PubMed
  49. Phys Sportsmed. 1989 May;17(5):128-40 - PubMed
  50. Eur J Appl Physiol Occup Physiol. 1992;64(1):1-8 - PubMed

Publication Types